Mast Therapeutics (MSTX)

Mast Therapeutics (MSTX) – FDA

Nov 3, 2016 09:16 AM Mast Therapeutics (MSTX) Announces Publication of Positive Interim Data from AIR001 Phase 2 in PH-HFpEF
Sep 20, 2016 05:02 PM Mast Therapeutics (MSTX) Reports Vepoloxamer Phase 3 in Sickle Cell Missed Primary Endpoint
Jul 12, 2016 01:48 PM
Jun 9, 2016 09:31 AM
Jun 6, 2016 04:36 PM
May 16, 2016 08:08 AM
Feb 22, 2016 06:24 AM
Feb 1, 2016 07:34 AM
Jan 7, 2016 12:01 PM
Nov 16, 2015 08:07 AM
Nov 9, 2015 08:17 AM
May 26, 2015 08:08 AM
Apr 21, 2015 08:13 AM
Mar 23, 2015 08:03 AM
Mar 2, 2015 08:24 AM
Feb 11, 2015 08:06 AM
Feb 4, 2015 08:03 AM
Jan 5, 2015 05:27 PM
Dec 10, 2014 08:42 AM
Dec 9, 2014 08:07 AM
Sep 16, 2014 06:49 AM
Sep 8, 2014 08:08 AM
Nov 13, 2013 07:08 AM
Jul 23, 2013 08:11 AM